ScinoPharm Taiwan, Ltd.

TWSE:1789.TW

24.9 (TWD) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) TWD.

202320222021202020192018201720162015201420132012201120102009
Operating Activities:
Net Income 348.84437.96302.286358.505265.054490.541475.302810.6802.884602.2091,408.5131,170.422961.3171,039.9551,039.294
Depreciation & Amortization 461.167439.465381.532393.197408.715405.821432.539444.841482.519471.101447.518363.268347.627366.827374.286
Deferred Income Tax 00011.404-162.133-167.639-274.415-181.982-184.65300078.65724.9950
Stock Based Compensation 0000.0842.055.68311.21210.1168.2679.4810.81900.94512.7460
Change In Working Capital -489.073-24.36-94.438254.346276.26453.917209.393449.462-120.967-7.845-630.306-556.231-122.653138.567-55.634
Accounts Receivables -154.865-259.60969.977195.7812.192100.48672.026238.29-352.802447.585-129.3126.683000
Inventory -347.47157.631-81.361-47.959293.845340.142101.41234.501211.519-0.74-647.254-441.576-243.826-274.679424.751
Accounts Payables -23.98655.574-89.98158.65311.625-1.39121.054-21.3337.247000000
Other Working Capital 37.24822.0446.92747.871-31.402113.775107.983214.961-332.486-7.10516.948-114.655121.173413.246-480.385
Other Non Cash Items -89.808-79.274-79.557-71.224-1.00143.271117.683131.98756.48-177.17-286.25243.59628.414-18.71-60.142
Operating Cash Flow 231.126773.791509.823946.312788.9451,231.594971.7141,665.0241,044.53888.295939.4731,021.0551,294.3071,564.381,297.804
Investing Activities:
Investments In Property Plant And Equipment -284.715-250.044-321.32-183.096-105.7-127.047-410.927-458.519-667.578-1,023.731-1,244.245-881.179-810.145-405.623-191.275
Acquisitions Net 0.1360.291-6.661-2.993-2.9974.0760.050.5550.4510-107.38800-225.980
Purchases Of Investments -0.136-47.982-348.913136.949-710.89-1,214.551-27.008254.937-284.21615.791-0.850000
Sales Maturities Of Investments 51.13244.149595.768283.501722.1291,039.230000-11.2310000
Other Investing Activites 0.293-0.03211.1457.359-0.931-1.7030.611.2647.6221.42617.22721.3320.629.326-28.598
Investing Cash Flow -233.29-253.618-69.981241.72-98.389-299.995-437.325-202.318-944.172-1,006.514-1,346.487-859.847-809.545-602.277-219.873
Financing Activities:
Debt Repayment -107.469-77.282-9.494-312.115-1,357.148-411.216-637.901-719.601-424.67200-0.9640-937.15-1,000.704
Common Stock Issued 000000000000957.021,172.5320
Common Stock Repurchased 000000000000000
Dividends Paid -284.666-379.555-395.37-213.5-387.462-379.555-228.098-219.325-140.592-811.113-779.916-631-6100
Other Financing Activities 51.158142.01-7.9180.707172.751163.734552.085801.307446.571589.347424.506263.357-0.2290-6.717
Financing Cash Flow -340.977-314.827-412.774-444.908-1,571.859-627.037-313.914-137.619305.979-221.766-355.41-367.643895.791235.382-1,007.421
Other Information:
Effect Of Forex Changes On Cash -10.0448.442-1.0956.846-17.057-12.015-16.83546.3671.757-21.8416.84-52.2344.766-28.758-13.537
Net Change In Cash -353.185213.78825.973749.97-898.36292.547203.641,371.454408.094-361.825-745.584-258.6691,385.3191,168.72756.973
Cash At End Of Period 3,941.5244,294.7094,080.9214,054.9483,304.9784,203.3383,910.7913,707.1512,335.6971,927.6032,289.4283,035.0123,293.6811,908.362739.635